198 related articles for article (PubMed ID: 20937768)
1. Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion.
Chen J; Luo Q; Yuan Y; Huang X; Cai W; Li C; Wei T; Zhang L; Yang M; Liu Q; Ye G; Dai X; Li B
Mol Cell Biol; 2010 Dec; 30(24):5621-35. PubMed ID: 20937768
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin-dependent acetylation of Pygo2 by CBP/p300 histone acetyltransferase family members.
Andrews PG; Kao KR
Biochem J; 2016 Nov; 473(22):4193-4203. PubMed ID: 27647933
[TBL] [Abstract][Full Text] [Related]
3. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
[TBL] [Abstract][Full Text] [Related]
4. MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits.
Zhang N; Ichikawa W; Faiola F; Lo SY; Liu X; Martinez E
Biochim Biophys Acta; 2014 May; 1839(5):395-405. PubMed ID: 24705139
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional activity of Pygopus is enhanced by its interaction with cAMP-response-element-binding protein (CREB)-binding protein.
Andrews PG; He Z; Popadiuk C; Kao KR
Biochem J; 2009 Aug; 422(3):493-501. PubMed ID: 19555349
[TBL] [Abstract][Full Text] [Related]
6. The Pygo2-H3K4me2/3 interaction is dispensable for mouse development and Wnt signaling-dependent transcription.
Cantù C; Valenta T; Hausmann G; Vilain N; Aguet M; Basler K
Development; 2013 Jun; 140(11):2377-86. PubMed ID: 23637336
[TBL] [Abstract][Full Text] [Related]
7. A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer.
Saxena M; Kalathur RKR; Rubinstein N; Vettiger A; Sugiyama N; Neutzner M; Coto-Llerena M; Kancherla V; Ercan C; Piscuoglio S; Fischer J; Fagiani E; Cantù C; Basler K; Christofori G
Cancer Res; 2020 Sep; 80(17):3631-3648. PubMed ID: 32586983
[TBL] [Abstract][Full Text] [Related]
8. Pygo2 siRNA Inhibit the Growth and Increase Apoptosis of U251 Cell by Suppressing Histone H3K4 Trimethylation.
Li M; Chao L; Wu J; Xu H; Shen S; Chen S; Gao X; Yu N; Wang Z
J Mol Neurosci; 2015 Aug; 56(4):949-955. PubMed ID: 25869613
[TBL] [Abstract][Full Text] [Related]
9. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of Myc-Dependent Mitotic Gene Expression by the Pygopus2 Chromatin Effector.
Andrews PGP; Popadiuk C; Belbin TJ; Kao KR
Cell Rep; 2018 May; 23(5):1516-1529. PubMed ID: 29719262
[TBL] [Abstract][Full Text] [Related]
11. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
Ishitani T; Ninomiya-Tsuji J; Matsumoto K
Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
[TBL] [Abstract][Full Text] [Related]
12. Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.
Zhang ZM; Wu JF; Luo QC; Liu QF; Wu QW; Ye GD; She HQ; Li BA
Oncogene; 2016 Sep; 35(36):4787-97. PubMed ID: 26876203
[TBL] [Abstract][Full Text] [Related]
13. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
Watanabe K; Fallahi M; Dai X
Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328
[TBL] [Abstract][Full Text] [Related]
14. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
15. The Wnt-β-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion.
Cai WY; Wei TZ; Luo QC; Wu QW; Liu QF; Yang M; Ye GD; Wu JF; Chen YY; Sun GB; Liu YJ; Zhao WX; Zhang ZM; Li BA
J Cell Sci; 2013 Jul; 126(Pt 13):2877-89. PubMed ID: 23613467
[TBL] [Abstract][Full Text] [Related]
16. p53 and microRNA-34 are suppressors of canonical Wnt signaling.
Kim NH; Kim HS; Kim NG; Lee I; Choi HS; Li XY; Kang SE; Cha SY; Ryu JK; Na JM; Park C; Kim K; Lee S; Gumbiner BM; Yook JI; Weiss SJ
Sci Signal; 2011 Nov; 4(197):ra71. PubMed ID: 22045851
[TBL] [Abstract][Full Text] [Related]
17. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
Hoffmans R; Basler K
Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor Lef1 switches partners from β-catenin to Smad3 during muscle stem cell quiescence.
Aloysius A; DasGupta R; Dhawan J
Sci Signal; 2018 Jul; 11(540):. PubMed ID: 30042129
[TBL] [Abstract][Full Text] [Related]
19. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers.
Yochum GS; Sherrick CM; Macpartlin M; Goodman RH
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):145-50. PubMed ID: 19966299
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid Receptor β Acts as a Co-activator of T-Cell Factor 4 and Enhances Glioma Cell Proliferation.
Wang Q; Lu PH; Shi ZF; Xu YJ; Xiang J; Wang YX; Deng LX; Xie P; Yin Y; Zhang B; Mu HJ; Qiao WZ; Cui H; Zou J
Mol Neurobiol; 2015 Dec; 52(3):1106-1118. PubMed ID: 25301232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
